Tzahi Cohen-Karni
Professor, Biomedical Engineering, Materials Science and Engineering
Professor, Biomedical Engineering, Materials Science and Engineering
Tzahi Cohen-Karni received both his B.Sc. degree in materials engineering and B.A. degree in chemistry from the Technion Israel Institute of Technology, Haifa, Israel, in 2004, his M.Sc. degree in chemistry from Weizmann Institute of Science, Rehovot, Israel, in 2006, and his Ph.D. in applied physics from the School of Engineering and Applied Sciences, Harvard University, Cambridge, in 2011. For his Ph.D. work, Cohen-Karni received the Gold Graduate Student Award from the Materials Research Society in 2009, and was awarded the 2012 IUPAC Young Chemist Award.
Cohen-Karni was a Juvenile Diabetes Research Foundation (JDRF) Postdoctoral Fellow at the Massachusetts Institute of Technology and Boston Children's Hospital in the labs of Robert Langer and Daniel S. Kohane, where he developed nanostructured three-dimensional platforms for cellular interfaces.
Currently, Cohen-Karni is an associate professor in the Department of Biomedical Engineering and the Department of Materials Science and Engineering at Carnegie Mellon University. His research interests include the unique interfaces between biology and nanotechnology, namely interfacing tissue and cells with nanostructures, monitoring their electrical properties, and altering their properties through controlled interactions with the nanostructures.
2011 Ph.D., Applied Physics, Harvard University
2006 MS, Chemistry, Weizmann Institute of Science
2004 BA, Chemistry, Technion Israel Institute of Technology
2004 BS, Materials Engineering, Technion Israel Institute of Technology
CMU Engineering
ARPA-H has awarded $45 million to a multi-institutional team of researchers to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths.
CMU Engineering
Multi-university team, led by Mechanical Engineering’s Vickie Webster-Wood, is building actuators for next generation sustainable bio-bots.
CMU Engineering
Sheng Shen’s novel 3D graphene-nanowire “sandwich” can enable a wide variety of electronic systems to operate at a lower temperature with higher performance.
CMU Engineering
Mayo Clinic and Carnegie Mellon University announced today a research agreement to transform organ transplantation. The institutions will bioengineer innovative approaches to address current barriers in organ transplantation.
NIH
BME/MSE’s Tzahi Cohen-Karni was recently awarded a $3.1 NIH/NHLBI grant to further cardiac electrophysiology research. Over the next five years, Cohen-Karni will partner with Pitt’s Aditi Gurkar (co-PI), BME/MSE’s Adam Feinberg, MechE’s Carmel Majidi, and ECE’s Pulkit Grover to study the role of DNA damage in the cardiac unit using induced pluripotent stem cells.
CMU Engineering
Using light to control how cells “talk” to one another isn’t new science, but researchers at CMU have discovered that MXene, an easily produced nanomaterial, can allow for effiicient cellular communication.
Multiple outlets
Research by BME/MSE’s Tzahi Cohen-Karni was featured in Florida News Times, as well as Knowledia, Asian Share, and Flipboard.
CMU Engineering
Carnegie Mellon researchers are working with DARPA, Northwestern University, and Rice University to develop a system for regulating the body’s circadian clock.
CMU Engineering
A forward-thinking group of researchers from Carnegie Mellon University and Istituto Italiano di Tecnologia has identified a flexible, low-cost, and biocompatible platform for enabling richer intracellular recordings.
Science Daily
BME/MSE’s Tzahi Cohen-Karni and ECE’s Maysam Chamanzar were featured in Science Daily for their new technology that enhances scientists' ability to communicate with neural cells using light.
CMU Engineering
A novel material for controlling human neuron cells could deepen our understanding of cell interactions and enable new therapies in medicine.
CMU Engineering
CMU has secured a $22 million DARPA grant to develop a device combining artificial intelligence, bioelectronics, and regenerative medicine to regrow muscle tissue, especially after combat injuries.